Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ironwood Pharmaceuticals Inc.

www.ironwoodpharma.com

Latest From Merck Serono SA

EU Marketing Approval In Sight For 11 Drugs After CHMP OK; Thumbs Down For Two

The European Medicines Agency’s key scientific committee, the CHMP, has recommended for approval throughout Europe a total of 11 new drugs. Two medicines received a negative opinion from the committee and the marketing authorization application for one product has been withdrawn. A further eight products are set to receive indication extensions. The medicines that got positive opinions are likely to secure official approval within the next few months.

Approvals Europe

EU CHMP Decides On New Oncology Drugs & New Treatments for Mastocytosis, Atopic Dermatitis

The European Medicines Agency’s key scientific committee, the CHMP, is deciding this week whether a dozen or so new medicines that are in the final stages of the evaluation process should be approved for marketing across the EU. The committee will discuss 13 initial marketing authorization applications.

Approvals Regulation

Asia Executives To Watch: FDA Names New India Director

FDA has named a new head for India while Roche has appointed a new VP for its anti-infectives and specialty care business unit in China. Personnel changes have also been effected at Bayer, Cook Medical, and the biopharma startup Kira Therapeutics.

Appointments StartUps and SMEs

Appointments: Eli Lilly, Alexion, Actelion, Polyphor, Constellation, Bone Therapeutics and Allied Minds

This week's roundup includes the announced retirement of Lilly's CFO, high-level appointments by Alexion Pharmaceuticals, Actelion and Constellation, and board elections by Wilson Therapeutics, Bone Therapeutics and Atlantic Healthcare.

BioPharmaceutical Appointments
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Gastrointestinal
  • Alias(es)
  • Microbia Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ironwood Pharmaceuticals Inc.
  • Senior Management
  • Peter M Hecht, PhD, CEO
    Thomas Graney, SVP, Fin. & Corp. Strategy & CFO
    Mark G Currie, PhD, SVP, CSO & Pres., R&D
    Christopher Wright, MD, PhD, SVP, Global Dev. & Chief Dev. Officer
    Thomas McCourt, Chief Commercial Officer & SVP, Mktg. & Sales
  • Contact Info
  • Ironwood Pharmaceuticals Inc.
    Phone: (617) 621-7722
    301 Binney St.
    Cambridge, MA 02142
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register